AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Divalna-ER 125 Tablet

Prescription Icon
Prescription Required

Marketer

Psyne Healthcare Pvt Ltd

Salt Composition

Divalproex (125mg)

Overview Divalna-ER 125 Tablet

Extended-release divalproex sodium 125 mg tablets are prescribed for epilepsy management, effectively preventing and controlling seizures. This medication also aids in migraine prophylaxis and may be employed in bipolar disorder treatment. Dosage and frequency are determined individually by your physician to optimize symptom control, and may be used alone or in conjunction with other medications. Administer at the same time daily, with or without food, for consistent efficacy; therapeutic effects typically manifest within several weeks. Continuous use, as directed, is crucial; discontinuation or missed doses can precipitate seizures and exacerbate the underlying condition; abrupt cessation is contraindicated. Common side effects, often mild, include headache, blurred vision, nausea, vomiting, dizziness, fatigue, gait instability, easy bruising, and hypothermia. Persistent or troublesome side effects warrant medical consultation. Report skin rashes immediately. Prolonged use increases osteoporosis risk and bone fracture likelihood. Rarely, suicidal ideation and behavior may occur; report any depressive symptoms to your doctor. Prior to initiating treatment, inform your physician of any history of cardiac issues, hepatic or renal impairment, urinary difficulties, depression, or suicidal tendencies. Drug interactions are possible; disclose all current medications to ensure safe usage. Consult your doctor before altering Divalproex sodium intake during pregnancy. Alcohol consumption should be avoided due to heightened side effect risk and increased seizure potential. Regular blood tests, both pre- and post-treatment, are usually necessary for optimal dosage monitoring.

Uses of Divalna-ER 125 Tablet

Managing epileptic seizures and bipolar disorder; migraine prevention.

Major Benefits of Divalna-ER 125 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Divalna-ER 125 Tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.

Common Side effects of Divalna-ER 125 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Divalna-ER 125 Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Divalna-ER 125 Tablets can be consumed with or without food, although consistent timing is recommended.

How Divalna-ER 125 Tablet works:

Extended-release Divalna 125 mg tablets are used to treat epilepsy. Their mechanism of action involves reducing hyperactivity within the brain's neuronal network, thereby managing seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Divalna-ER 125 Tablets and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Divalna-ER 125 Tablet during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release divalproex sodium 125 mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Divalna-ER 125 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Divalna-ER 125 Tablets without requiring any dosage modification.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Divalna-ER 125 Tablets due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Divalna-ER 125 Tablet :

Should you forget a Divalna-ER 125 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Divalna-ER 125 Tablet

LabelValue
Chemical Category Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Action Class Sodium channel-blocking antiepileptic drugs

FAQs on Divalna-ER 125 Tablet

Always consult your doctor before discontinuing Divalna-ER 125 Tablet. Withdrawal should be gradual, under medical supervision, to avoid potential complications such as symptom recurrence, irritability, anxiety, dizziness, or tremors.
Divalna-ER 125 Tablets can act as a mood stabilizer in some cases, particularly for individuals experiencing rapid mood swings. The medication achieves this by reducing excessive brain activity associated with these mood changes.
Divalna-ER 125 Tablets can cause weight gain, possibly from increased appetite. Manage your diet and exercise to minimize this risk. Consult your doctor about any weight concerns.
Divalna-ER 125 Tablets may cause drowsiness. Refrain from driving or activities requiring alertness until you understand the drug's effects on you.
Hair loss is a possible, temporary side effect of Divalna-ER 125 Tablet, often related to dosage. Consult your doctor if this side effect concerns you or continues.
Divalna-ER 125 Tablets can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice. Liver function tests are recommended before starting, and regularly during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Refrain from drinking alcohol during your Divalna-ER 125 Tablet treatment. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Divalna-ER 125 Tablet treatment, your doctor may order blood tests. These may include a complete blood count (with platelets), bleeding time, and coagulation studies to minimize bleeding risks. Liver function tests are also recommended before, and regularly monitored during the first six months of treatment, especially for high-risk individuals or those with a history of liver disease.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; if positive for pancreatitis, medication should be stopped immediately.
Divalna-ER 125 Tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Additional symptoms may include muscle weakness, seizures, loss of consciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Divalna-ER 125 Tablet
37
MRP 45
17% off